期刊文献+

育龄期未生育PCOS患者子宫体体积与临床标志物的相关性分析 被引量:2

Volume of corpus uteri in nulliparous women of reproductive age with polycystic ovarian syndrome and its correlation with clinical indicators
下载PDF
导出
摘要 目的分析育龄期未生育多囊卵巢综合征(PCOS)患者子宫体体积与代谢、内分泌、出凝血等指标及子宫动脉血流的相关性,为PCOS患者临床治疗和预后预测提供参考。方法选取2015年10月至2016年9月在上海交通大学医学院附属仁济医院就诊的育龄期未生育PCOS患者353例及正常未生育女性102例,超声检测子宫体大小及子宫动脉血流相关指数。PCOS患者按照子宫体大小的四分位间距分为子宫体体积偏小组、中间组及偏大组。检测PCOS患者的体质指数(BMI)、性激素、血糖及胰岛素等代谢及内分泌指标并进行相关性分析。结果育龄期未生育PCOS患者子宫体体积较正常女性偏小(Z=2.572,P<0.05),子宫动脉阻力指数(RI)、收缩期峰值速度/舒张末期血流速度(S/D)偏高(左:t值分别为2.961、3.531,均P<0.05;右:t值分别为2.413、2.804,均P<0.05)。子宫体体积偏小组、中间组及偏大组的患者年龄、黄体生成素、黄体生成素/卵泡刺激素(LH/FSH)比值、总胆固醇水平及子宫动脉血流阻力比较差异均有统计学意义(F值分别为6.898、6.483、7.228、4.742、3.054、5.142、4.454、4.542,均P<0.05)。结论子宫体体积偏小是育龄期未生育PCOS患者的主要临床表现之一,且与生殖内分泌紊乱程度、脂代谢异常及子宫动脉血流阻力升高相关。 Objective To analyze the correlation between volume of corpus uteri and metabolism,endocrine,bleeding and coagulation,and uterine artery blood flow in nulliparous women of reproductive age with polycystic ovary syndrome( PCOS) so as to provide reference for clinical treatment and prognosis of PCOS patients. Methods A total of 353 nulliparous patients with PCOS and 102 nulliparous healthy women were collected in department of obstetrics and gynecology of Renji Hospital during October 2015 to September 2016. Volume of corpus uteri and uterine artery blood flow indexes were detected by ultrasound. PCOS patients were divided into 3 groups according to the lower and upper quartile of volume of corpus uteri: smaller volume group,middle volume group and larger volume group. BMI,sex hormones levels,blood glucose and other metabolic and endocrine indicators were collected for correlation analysis in patients with PCOS.Results Volume of corpus uteri in nulliparous PCOS patients was found to be smaller than that of women with normal menstruation cycle( z = 2. 572,P 0. 05) and with higher uterine artery RI and S/D( tL-RIvalue was 2. 961 and 3. 531,tR-RIvalue was 2. 413 and 2. 804,respectively,all P 0. 05). The differences in patient's age,luteinizing hormone,LH/FSH ratio,total cholesterol level and uterine artery RI were statistically significant among three groups( F value was 6. 898,6. 483,7. 228,4. 742,3. 054,5. 142,4. 454 and 4. 542,respectively,all P 0. 05). Conclusion Smaller volume of corpus uteri is one of the remarkable clinical manifestations in nulliparous PCOS patients of reproductive age. It is likely related to the severity of reproductive-endocrine disorder,lipid metabolism disorders and increased uterine artery blood flow resistance.
出处 《中国妇幼健康研究》 2017年第9期1065-1068,共4页 Chinese Journal of Woman and Child Health Research
基金 上海市卫计委公共卫生三年行动计划重点学科资助项目(15GWZK0701)
关键词 多囊卵巢综合征 子宫体体积 黄体生成素 子宫动脉血流 polycystic ovarian syndrome(PCOS) volume of corpus uteri luteinizing hormone uterine artery blood flow
  • 相关文献

参考文献2

二级参考文献26

  • 1Fauser BC, Tarlatzis BC, Rebar RW, et al. Consensus on women's health aspects of polycystic ovary syndrome(PCOS) : the Amsterdam ESHRE/ASRM-Sponsored 3rd PCOS Consensus Workshop Group [ J ]. Fertil Steri1,2012,97 ( 1 ) :28-38, e25.
  • 2Hart R. PCOS and inferlility[J]. Panminerva Med,2008,50(4) : 305-314.
  • 3Ghazeeri GS, Nassar AH, Younes Z, et al. Pregnancy outcomes and the effect of metformin treatment in women with polycystic ova-ry syndrome: an overview[ J]. Acta Obstet Gynecol Scand,2012, 91 (6) :658-678.
  • 4Randeva HS, Tan BK, Weickert MO, et al. Cardiometabolic as- pects of the polycystic ovary syndrome[ J]. Endocr Rev,2012,35 (5) :812-841.
  • 5Kazerooni T, Ghaffarpasand F, Asadi N, et al. Colxelation be- tween thrombophiha and recurrent pregnancy loss in patients with polycystie ovary syndrome: a comparative study [J]. J Chin Med Assoc, 2013,76 ( 5 ) : 282 -288.
  • 6Rotterdam EA-SPcwg. Revised 2003 consensus on diagnostic crite- ria and long-term health risks related to polycystie ovary' syndrome (PCOS) [ J]. Hum Reprod ,2004,19 ( 1 ) :41-47.
  • 7Kebapcilar L, Taner CE, Kebapeilar AG, et al. High mean plate- let volume, low-grade systemic coagulation and fibrinolytic activa- tion are associated with androgen and insulin levels in polycystic o- vary syndrome [ J ]. Arch Gyneeol Obstet,2009,280 ( 2 ) : 187-193.
  • 8Idali F, Zareii S, Mohammad-Zadeh A, et al. Plasminogen activa- tor inhibitor 1 and methylenetetrahydrofolate reductase gene muta- tions in Iranian women with polycystic ovary syndrome[ J]. Am J Reprod Immunol,2012,68(5) :400-407.
  • 9Vanky E, Salvesen KA, Hjorth-Hansen H, et al. Beneficial effect of metformin on pregnancy outcome in women with polycystie ovary syndrome is not associated with major changes in C-reactive protein levels or indices of coagulation [ J] . Fertil Steril, 2006,85 ( 3 ) : 770-774.
  • 10Ramidi G, Khan N, Glueck C J, et al. Enoxaparin-mettbrmin and enoxaparin alone may safely reduce pregnancy loss [ J ]. Transl Res,2009,153 ( 1 ) :33-43.

共引文献49

同被引文献19

引证文献2

二级引证文献16

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部